SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -94.5% | 20,749 | -89.1% | 0.00% | – |
| Q1 2022 | $128,000 | -82.0% | 190,670 | -65.5% | 0.00% | – |
| Q4 2021 | $713,000 | -16.1% | 552,734 | +41.1% | 0.00% | – |
| Q3 2021 | $850,000 | +217.2% | 391,632 | +298.5% | 0.00% | – |
| Q2 2021 | $268,000 | +20.7% | 98,284 | +15.8% | 0.00% | – |
| Q1 2021 | $222,000 | +138.7% | 84,895 | +152.5% | 0.00% | – |
| Q4 2020 | $93,000 | – | 33,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
| Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
| Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
| Prosight Management, LP | 256,115 | $699,000 | 0.44% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
| KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
| Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
| APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |